Time & Date: 3 September, 11:00 – 12:00 CEST
Moderator: I. Rospond-Kubiak POLAND
Speakers & Presentations:
I. Rospond-Kubiak POLAND
11:00 Welcome
A. Casablanca Piñera SPAIN
11:02 Endoretinal Biopsy for the Diagnosis of Vitreoretinal Lymphoma
V. Reçi MACEDONIA
11:07 Unilateral infiltration of the optic nerve and orbit as a sign of recurrence of acute lymphoblastic leukemia
A. Turae GEMRANY
11:12 Influence of radiotherapy on the extent of DNA damage in the uveal melanomas with monosomy-3
S. Grisanti GERMANY
11:17 Value of Liquid Biopsy for intermediate melanocytic lesions of the uvea
B. Batu Oto TURKEY
11:22 Treatment Outcomes of Retinal Capillary Hemangioblastomas in a Tertiary Care Center: Retrospective Case Series
H. Quhill UK
11:27 Patient-reported outcomes for ocular melanoma patients discharged to their local hospital eye services during the COVID-19 pandemic
V. Kakkassery GERMANY
11:32 Comparative proteomic analysis of etoposide sensitive and etoposide resistant retinoblastoma cells unveils novel signaling mechanisms in chemotherapy resistance
I. Rospond-Kubiak POLAND
11:37 Indocyanine green-enhanced transpupillary thermotherapy (ICG-TTT) for circumscribed choroidal hemangioma
M. Nowara EGYPT
11:42 Combining Ablation Therapy with Intravitreal Ranibizumab in Managing Exudative Coats’ Disease: A Five-Year Single Center Experience
K. Eibenberger UK
11:47 Retinal vasculature following ruthenium plaque radiotherapy in choroidal melanoma
All Faculty
11:52 Discussion
